Cell and Gene Therapy Catapult

Activities: Cell & Gene Therapy

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Finance

Horiba joins cell & gene therapy manufacturing consortium

Headed by the Cell and Gene Therapy Catapult, the consortium comprises technology providers, pharmaceutical companies, therapy developers and charities
Regulatory

NHC named National Training Centre for UK skills initiative

The National Horizons Centre will provide hands-on training for advanced therapy medicinal products (ATMPs) and vaccine manufacture
Finance

Stevenage cell and gene therapy facility receives £3m government grant

The cell and gene therapy cluster around Stevenage has reportedly been recognised as a high potential opportunity zone, set to attract overseas investment to the
Regulatory

CGT Catapult analyses manufacturing and skills in cell and gene therapy

New data has shown cell and gene therapy manufacturing facilities are rapidly becoming operational reflecting job expansion in the sector
Media

British cell and gene therapy accelerator releases annual report

The CGT Catapult has worked on more than 110 projects addressing industry challenges
Research & Development

CGT Catapult brings SMEs together

Fujifilm Diosynth, Eversheds Sutherland, Mathys & Squire and Stifel gather at CGT Catapult’s first UK Advanced Therapy Medicinal Products Investor Day
Research & Development

TCR2 Therapeutics and CGT Catapult join forces at UK Bioscience park

TCR<sup>2</sup> is the first US company to have a global development base at the Stevenage site, working with CGT Catapult to further its T cell therapies
Subscribe now